JPMorgan added PTC Therapeutics to its list of favorite stocks as the new month gets under way. Every month, the bank refreshes its analyst focus list, which includes the top ideas from JPMorgan analysts aligned with growth, income, value and short investment strategies. The bank’s changes come after stocks notched a solid performance in August , which is a historically weak month for the major benchmarks. Lifting investors’ spirits heading into September is optimism that the Federal Reserve will finally begin to cut rates at its meeting this month. The CME FedWatch tool shows the market has now priced in a nearly 90% chance of this happening. Additions in the past four weeks to JPMorgan’s focus list included ACV Auctions , Cellebrite , McCormick , PTC Therapeutics and Armstrong World Industries . On the other hand, the bank removed Roivant , BellRing Brands , Edgewise Therapeutics and Carlisle from its basket. Biopharma stock PTC Therapeutics has surged 16% this year. JPMorgan’s $68 price target is about 38% higher than where shares closed on Friday. In May, Bank of America upgraded the stock to a buy rating from neutral, citing the launch of the company’s new program focused on phenylketonuria, or PKU, a rare metabolic disease. This program could lead to around $788 million in peak risk-adjusted sales, wrote analyst Tazeem Ahmad. To accompany the upgrade, Bank of America raised its price target to $68 per share from $55. Manufacturing stock Armstrong World Industries was another name on JPMorgan’s list. Shares have soared 37% in 2025 but could rise another 7% to the bank’s $210 price target. JPMorgan initiated the stock at an overweight rating in June. “Armstrong represents a rare combination of operational stability and embedded innovation,” wrote analyst Tomohiko Sano. “From thermal ceiling technologies like TEMPLOK to AI-enabled design support via ProjectWorks, AWI is expanding value across segments, driving both top line and profitability through shared platforms. This redefinition elevates AWI from a building materials manufacturer to a solutions-oriented, building performance company.” Sano also applauded the company’s strong margin stability, even through end-market volatility, as well as its potential for multiple expansion and margin improvements. Two other additions to JPMorgan’s focus list included food manufacturer McCormick and auto auction platform ACV Auctions.
